Immuneering: Immuneering to Present at the Leerink Global Healthcare Conference

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that management will present at the Leerink Global Healthcare Conference, taking place in Miami, Florida, from March 9-11, 2026. Ben Zeskind, Chief Executive Officer, will discuss the company's pipeline, platform, and business strategy.Format: Fireside Chat and 1x1 Investor MeetingsDate/Time: Monday, March 9, 2026, from 3:40 - 4:10 pm ETFull story available on Benzinga.com